Free Newsletter
Watch the door, take the keys
It's been a good summer for drug theft. Mylan subsidiary Dey announced last Wednesday the theft of two lots of its Albuterol sulfate inhalation unit-dose vials. GlaxoSmithKline announced Monday that two lots of Advair Diskus medication were stolen earlier this month from the company's distribution facility near Richmond, VA, while awaiting shipment to retail pharmacies.
Both announcements mentioned, of course, that the stolen doses could represent a health risk and should not be sold because the storage conditions outside their normal supply chains are unknown.
And as we reported in late July, Sanofi-aventis recently lost to thieves a trailer full of the blood thinner Lovenox, the antihistamines Xyzal and Nasacort AQ nasal spray, and acne treatment BenzaClin Gel. The shipment contained, according to Securing Pharma.
A recent UPS supply chain survey found that serialization is rising as concern among drug makers, likely in response the rising amount of trailer thefts, especially those involving controlled substances.
- here's the Dey announcement
- see the GSK notice
- see our coverage of the Sanofi-aventis theft
- here's information on the UPS survey
Related Article:
Material shortages make opportunity for theft
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




